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Background: Pharmacology is a biomedical discipline taught in basic science and professional degree programs. In
order to provide information that would facilitate pharmacology curricula to be refined and developed, and
approaches to teaching to be updated, a national survey was undertaken in Australia that investigated
pharmacology course content, teaching and summative assessment methods.
Methods: Twenty-two institutions participated in a purpose-built online questionnaire, which enabled an evaluation
of 147 courses taught in 10 different degrees. To enable comparison, degrees were grouped into four major degree
programs, namely science, pharmacy, medicine and nursing. The pharmacology content was then classified into 16
lecture themes, with 2-21 lecture topics identified per theme. The resultant data were analysed for similarities and
differences in pharmacology curricula across the degree programs.
Results: While all lecture themes were taught across degree programs, curriculum content differed with respect to
the breadth and hours of coverage. Overall, lecture themes were taught most broadly in medicine and with
greatest coverage in pharmacy. Reflecting a more traditional approach, lectures were a dominant teaching method
(at least 90% of courses). Sixty-three percent of science courses provided practical classes but such sessions
occurred much less frequently in other degree programs, while tutorials were much more common in pharmacy
degree programs (70%). Notably, problem-based learning was common across medical programs. Considerable
diversity was found in the types of summative assessment tasks employed. In science courses the most common
form of in-semester assessment was practical reports, whereas in other programs pen-and-paper quizzes
predominated. End-of-semester assessment contributed 50-80% to overall assessment across degree programs.
Conclusion: The similarity in lecture themes taught across the four different degree programs shows that common
knowledge- and competency-based learning outcomes can be defined for pharmacology. The authors contend that
it is the differences in breadth and coverage of material for each lecture theme, and the differing teaching modes
and assessment that characterise particular degree programs. Adoption of pharmacology knowledge-based learning
outcomes that could be tailored to suit individual degree programs would better facilitate the sharing of expertise
and teaching practice than the current model where pharmacology curricula are degree-specific.
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The discipline of pharmacology embraces both the ex-
perimental and clinical sciences. Experimental pharma-
cology is vital to our understanding of drug action in the
treatment of disease as well as to the pharmaceutical in-
dustry for drug discovery and development. Clinical
pharmacology is essential for prescribing practice in
medicine and nursing and underpins pharmacy practice
and therapeutics. Pharmacology includes a number of
branches such as pharmacodynamics, pharmacokinetics
and therapeutics, and is taught in non-vocational, science
degree programs and vocational, health professional pro-
grams. Currently, there are significant challenges and
opportunities facing the teaching and learning of pharma-
cology. The applied nature of the discipline, the move to-
wards integrated course structures, the deconstruction of
discipline boundaries and increasing numbers of students
seeking higher education raise issues concerning retention
of subject-based discipline integrity, scope of material
taught and maintenance of academic standards. These is-
sues also provide opportunities to interact with other bio-
medical and clinical disciplines, educate a larger number
and broader range of students, and to develop strategies
to advance the discipline and adapt teaching and learning
methods. Evaluation of current pedagogical approaches to
pharmacology teaching in Australia is, therefore, not only
an important first step towards addressing the aforemen-
tioned challenges, but will facilitate curriculum refresh
and design. These are significant issues for stakeholders in
the educational sector, the pharmaceutical industry and
the health professions.
In the face of a growing movement to dismantle
discipline boundaries, there is evidence from clinical
practice that inadequate pharmacology knowledge is a
growing concern, raising the question of the true role of
disciplines and in particular the integrity of pharmaco-
logy as foundation material essential to safe and effective
practice. In a survey conducted in Australia [1], only
13% of teaching staff agreed unequivocally that nursing
graduates had sufficient knowledge for safe practice. In
2008, the Australian Medical Education Study (AMES)
of medical students, junior doctors and educators/em-
ployees revealed that clinical pharmacology was one of
the least successful components of medical education
[2]. Indeed, only 39% of medical students considered
that they were adequately or well prepared in clinical
pharmacology. This finding reinforced that of a survey
of graduating medical students in the UK in which
deficiencies in the areas of basic pharmacology, phar-
macokinetics and therapeutic drug monitoring were
highlighted by 53-59% of the medical graduates surveyed
[3]. Subsequently, Heaton and colleagues [4] published
the views of 2413 UK medical students and recent grad-
uates on prescribing preparation; the majority view wasthat teaching and assessment in this area was inad-
equate. A study undertaken by Dornan and co-workers
[5] demonstrated the gravity of the situation when it was
determined that there was an error rate of 8-10% in
prescription writing. These studies indicate significant
deficiencies in medical pharmacology education even
though learning outcomes for pharmacology in medical
curricula are apparently well represented [6].
Comparable concerns have been raised by the bio-
pharmaceutical industry. The Pharmaceuticals Education
Council (PEC) of Australia, which was set up in 2003 to
investigate pharmaceutical workforce needs, reported
that employers were concerned about a lack of job-ready
graduates skilled in drug discovery and development. To
address this issue, the PEC recommended that pharma-
cology and other biomedical sciences be introduced into
postgraduate courses [7].
The deficiencies highlighted above in teaching and
perceptions of learning of pharmacology raise an initial
vital question: “what and how” are we teaching pharma-
cology? Surprisingly few studies have addressed this. In
1990, Walley and colleagues [8] conducted a survey of
pharmacology teaching in medical degrees in the UK
based on 17 areas of core information, 16 core skills and
5 core attitudes that were regarded as representing a
core curriculum for clinical pharmacology [9]. They
found that there was good agreement about the import-
ance of certain areas (e.g. prescribing for the elderly,
management of overdose and adverse drug reactions)
and that these areas were widely taught (85-100% of all
degrees surveyed); nevertheless, there was considerable
variation in how extensively other areas were taught (e.g.
efficacy and toxicity of non-prescription drugs, taught
by 35%).
In 1996, the Education Sub-committee of the British
Pharmacology Society (BPS) conducted a survey of the
content of Bachelor of Science (BSc) pharmacology cour-
ses [10]. Significant variation in pharmacology course con-
tent was found across the universities surveyed, with only
a limited number of topics being taught in depth. In a
second survey conducted in that same year, 78% of tea-
ching was found to be chalk and talk lectures, reflec-
ting a traditional approach to pharmacology teaching
[11]. Arising out of these findings was a call by the
BPS for a pharmacology core curriculum for BSc degree
programs to parallel the development of a core curriculum
in clinical pharmacology for medical programs. One clear
advantage of a core curriculum is that it can address the
issue of content overload, where content is added ad hoc
but nothing is removed; a phenomenon referred to as
‘coveritis’ [12,13].
In recent years, the BPS and the Australasian Society
of Clinical and Experimental Pharmacologists and Toxi-
cologists (ASCEPT) have created pharmacology core
Table 1 Participating institutions and academic staffing
levels
Institution Number of full time academic
staff teaching pharmacology
Australian National University 4
Bond University 5




James Cook University 2
La Trobe University 2
Monash University 12
Murdoch University 3
Queensland University of Technology 5
RMIT University 9
University of Adelaide 7
University of Melbourne 11
University of Notre Dame 3
University of South Australia 6
University of Southern Queensland 2
University of Sydney 13
University of Technology, Sydney 2
University of Tasmania 3
University of Western Australia 9
University of Western Sydney 1
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veterinary science courses, with each curriculum devel-
oped for a single program. In the USA, the Association
for Medical School Pharmacology published The Know-
ledge Objectives in Medical School Pharmacology [14]
and the International Union of Basic and Clinical Phar-
macology (IUPHAR) has, through its website, made
available 35 pharmacology curricula used in pharmacy,
medicine, and science degree programs in different
institutions and countries. In 2008, the Association of
American Medical Colleges (AAMC) released a report
on safe and effective prescribing practices, which in-
cludes six tables containing the broad learning objec-
tives ideally taught and evaluated at medical schools
[15]. In a recent version of Tomorrow’s Doctors [16],
published by the General Medical Council (UK), there
is guidance on knowledge pertaining to basic and
clinical pharmacology for doctors.
Surveys previously undertaken have compared the
“what and how” of pharmacology teaching in specific de-
gree programs at different institutions [1,10,17,18]. To
our knowledge, no study has compared the “how” as well
as the “what” of pharmacology teaching across different
degree programs at a national level. The purpose of our
study was to investigate content and teaching me-
thodology across degree programs in order to compare
curricula. Specifically, this study was designed to provide
a snapshot of the current approaches to the delivery and
assessment of pharmacology content, rather than stu-
dent learning, across courses and programs in which
pharmacology was taught (at Bachelor and Masters
levels) at higher education institutions across Australia.
Our view is that commonalities in content and approach
have the potential to better facilitate the sharing of ex-




Of the 39 higher education institutions in Australia, 37
were identified that teach pharmacology and contact was
made with relevant personnel in each institution after
ethics approval had been obtained. Of the 37 institutions
contacted, 27 agreed to participate (73% response rate)
and of those, staff from 22 completed the survey
(81% completion rate) (Table 1). Participating institu-
tions formed a representative sample of universities in
Australia, including research-intensive (Group of Eight),
Australian Technology Network and regional universities,
and all degree programs into which pharmacology is
taught. Since the breadth of degree programs are also
taught across the institutions that did not participate, our
data are generalisable to those institutions. Individual par-
ticipants were full- or part-time academic staff memberswho were fluent in English (as a first or second language).
Informed consent was implicit in completion of the
survey.
Terminology
Definitions of the following terms are provided in Table 2
for clarification: degree program, course, theme, topic,
stand-alone course, and integrated course.
Survey instrument
The online questionnaire consisted of 18 open- and
closed-ended questions, with multiple response catego-
ries. The questionnaire was designed by the project team
to provide insight into the pedagogical approaches to
the delivery of pharmacology content during the years
2008-9 offered within science, pharmacy, nursing and
medicine Bachelor and Masters degrees in Australia.
The questionnaire was divided into five parts: A - E. The
time required to complete the questionnaire varied from
one to several hours depending on the number of phar-
macology courses offered by a given institution and the
number of staff members available to assist with survey
completion.
Table 2 Definitions of key terms*
Term Definition
Degree program One of four core areas of study, namely
science, pharmacy, nursing and medicine for
which a university degree is obtained
Course Credit point unit of study within a degree.
Some institutions refer to this as a subject or unit
Theme A broad, primary concept within pharmacology
and toxicology. For the purpose of this article,
themes are drawn from lecture content
Topic A specific, secondary concept within a theme.
For the purpose of this article, these topics are
drawn from lecture content
Stand-alone course A course dedicated entirely to the discipline of
pharmacology as an independent field of study
Integrated course A course in which pharmacology is one of
many disciplines taught using a blended
approach to the content
*Terminology occasionally varied substantially between institutions that
contributed to this study. Key terms were chosen based on frequency of use
amongst institutions and the potential for generalisability of terminology
across institutions in other countries.
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ching at participating institutions was solicited. Part A of
the questionnaire sought information about the total
number of full-time academic staff employed, the num-
ber of academic staff teaching pharmacology, the year
level(s) when pharmacology was taught, the numbers of
students enrolled in courses containing pharmacology
and whether those courses were delivered in a stand
alone or integrated mode.
The breadth and coverage of pharmacology content
were addressed in Part B of the survey. Sixteen lecture
themes were identified within the course content, and
each theme was sub-divided into a number of lecture
topics. The categorisation of fifteen key themes and
topics was developed using a combination of pharmacolo-
gy principles, systems-based pharmacology and disease-
based therapeutics referenced against the Tables of
Contents of a selection of commonly used pharmacology
texts and clinical reference handbooks; for example, phar-
macokinetics is a theme, for which drug metabolism is a
topic within that theme. The appropriateness of the list of
themes and topics was verified and finalised in a pilot
study of pharmacology courses from eight institutions.
Only two lecture topics were identified for some lecture
themes, while up to 21 were identified for others. The list
of lecture themes and topics was then incorporated into
the questionnaire (see Table 3). Survey participants were
asked to reference their responses against this list in order
to standardise the collected data. The sixteenth theme was
classified Miscellaneous to capture topics that failed to fit
within the previous 15 themes. The topics identified
within this theme were derived post hoc from survey re-
sponses and are included in Table 3.Information about the different types of teaching me-
thods used (e.g. lectures, wet and computer laboratories
and tutorials) and the time spent utilising each method
was obtained in Part C. The summative assessment
methods employed and the relative proportion of in-
semester versus end-of semester assessment was ob-
tained in Part D. Information about formative assess-
ment methods was not collected in the survey. Finally,
Part E addressed the type, level and frequency of course
evaluation.
Initially, a trial questionnaire was created using a for-
matted Excel spreadsheet. Instructions guided respon-
dents on how to complete the questionnaire: to choose
from a drop down menu (with pre-coded response op-
tions) or to fill in the space provided. Amendments to
navigation and ease of use were made in the pilot study,
in addition to changes required with respect to the veri-
fication of themes and topics. The finalised question-
naire was scripted in Microsoft Word (National Field
Services, Melbourne, Australia) and further iterations
and amendments were made during the scripting pro-
cess. The final questionnaire was hosted online using
SPSS software (SPSS Inc., Chicago, Illinois, USA) by Na-
tional Field Services (Australia). In accordance with the
requirements of the project funding body, the Australian
Learning and Teaching Council, the questionnaire is
openly available on request.
Data collection and ethics approval
Ethics approval was obtained from Human Research
Ethics Committees of participating institutions of the pro-
ject team. The ethics approval numbers were: 11-2008/
11375 for the University of Sydney and MUHREC CF09/
0656: 2009000215 for Monash University. Human Re-
search Ethics Committees at the University of Western
Australia, the University of Melbourne, the University of
Adelaide, RMIT and James Cook University granted ap-
proval for this study based on ethics approval obtained
from University of Sydney in accordance with their re-
spective policies allowing for the recognition of ethics ap-
proval by an external Human Research Ethics Committee
and/or in tandem with the ethics approval for a compan-
ion survey of student perceptions on teaching. Following
this, letters were sent to Heads of Department/School of
all higher education institutions identified in which
pharmacology was taught inviting participation in the sur-
vey and requesting contact details of a nominated liaison
person for that Department/School. Liaison individuals
were then contacted by email or phone and provided
with details about the survey, participant information
and questionnaire instructions. Follow-up contact was
made via email two and three weeks later to all liaison
persons to remind them of the survey completion
date. The liaison person completed and/or requested
Table 3 Lecture topics provided for each lecture theme in
the survey
Lecture theme Lecture topic
Pharmacodynamics Introduction to Pharmacology/Drug Action
Drug-receptor interactions
Drug targets (receptors, enzymes, transporters)




Models of drug action/Pharmacodynamics
Determinants of drug potency/effectiveness
Physicochemical properties of drugs



































Research methods in Pharmacology
(pre-clinical)
Intellectual property commercialisation in
Pharmaceuticals




How drugs reach the market/Drug registration
Therapeutic drug monitoring/Regulatory affairs/
Drug laws




Autacoids (Histamine, 5-HT, Eicosanoids)
Central nervous system
Neuropeptides, proteins and purines
(cannabinoids, purines, endogenous opioids,
NPY, substance P, etc.)
Neurotransmitters (catecholamines,







Dementia/Drugs for dementia/Drugs for
cognition
Motor control/Movement disorders/Drugs for
movement disorders
Neurodevelopment/Neurodegeneration
Multiple sclerosis (and demyelinating diseases)/








Respiratory drugs Drugs for asthma (bronchodilators,






Drugs for heart failure
Drugs for dyslipidaemia/hypercholesterolaemia
Drugs for angina/Myocardial infarction
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Table 3 Lecture topics provided for each lecture theme in
the survey (Continued)
Gastrointestinal drugs Drugs for dyspepsia, reflux and peptic ulcers
Drugs affecting gastrointestinal motility
Antinauseants/Antiemetics
Drugs for inflammatory bowel disease
Musculoskeletal drugs Drugs for gout and hyperuricaemia







Drugs for labour/Uterine drugs
Corticosteroids/Drugs for adrenal disorders
Androgens and anabolic steroids
Drug treatment of impotence and prostate
disease
Hormone replacement therapy/Oestrogens
Thyroid and antithyroid drugs
Drugs for obesity, energy balance and appetite


























Foods and beverages as drugs
Future therapies Gene therapy/RNA therapies
Antibody therapies
Table 3 Lecture topics provided for each lecture theme in
the survey (Continued)
Drugs of abuse Addiction/Drug dependence
Drugs of abuse (Cocaine, LSD, MDMA,
Cannabis, Heroin, Alcohol, BZs etc.)
Pharmacological management of addiction
Drugs in sport
Nootropic agents
Miscellaneous Drugs for liver disease
Ethics
Drugs for eczema, psoriasis and acne
Drugs for anaemia
Information sources about drugs
Equity of access to drugs
Drugs and the oral cavity
Prescription writing and the PBS
Other (as specified by participants)
- statistics
- communication skills
- free radicals and cell damage
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complete the questionnaire.
Data analysis
Questionnaire data were exported from SPSS data files
to Microsoft Excel spreadsheets and analysed. The ori-
ginal study examined a number of degree programs in
addition to those described here into which pharma-
cology is taught, such as dentistry, optometry and veter-
inary medicine, however only the major four (science,
pharmacy, nursing and medicine) are presented here.
Descriptive statistics from this pooled data were ex-
tracted and reported, including frequency counts, per-
centages, means, medians and ranges.
Breadth and coverage of pharmacology content in
different degree programs
A key aspect of the data analysis was to determine the
breadth of lecture themes and lecture topics taught in
the different degree programs, and to obtain an index of
the coverage of each. The breadth of content was de-
fined in two ways: 1) the identification of lecture themes
taught in each course and the percentage of courses in a
Table 4 Specific degrees included for each degree program
Degree program* Degrees included Number of courses** Number of institutions
Science Science, Medical Science, Biomedical Science, Pharmaceutical Science,
Pharmaceutical Engineering, Health Science, Biotechnology
59 14
Pharmacy Pharmacy 41 10
Nursing Nursing 24 11
Medicine Medicine 27 10
*While many Australian institutions diversify their degree offerings, for example, offering a Bachelor of Science as well as a Bachelor of Biomedical Science and a
Bachelor of Biotechnology, this is not true of all institutions, nor is this necessarily generalisable to institutions outside Australia. Choice of categories was based in
part on the recognition that programs for which a student might obtain a discrete named degree in Australia might constitute a major or focus of a more
generally-named degree elsewhere (e.g. a major in Biotechnology is found in some Bachelor of Science degrees). It should be noted that the Medicine degree cat-
egory does not distinguish between graduate-entry and undergraduate programs.

























Figure 1 Student enrolment numbers for courses within each
degree program. Data are represented as median enrolment
number; ranges are given above each bar.
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and 2) the percentage of courses that addressed a par-
ticular topic within a theme.
The extent of coverage of each topic is defined as the
average number of lectures devoted to the topic within a
theme. This is represented as an index of content cove-
rage using the following calculation:
average number of topic lectures per theme
total number of topics per themeð Þ
 fraction of topics taught per themeð Þ:
A resultant index greater than 1 represents greater
than 1 lecture per topic within a given theme.
Results
Context in which pharmacology is taught
There was great diversity in the characteristics of the 22
institutions that participated in the survey in terms of
staff numbers (1-13), staff:student ratios, total student
enrolment (4,000–40,000), and location (urban and re-
gional). Across these 22 institutions, 147 courses were
identified into which pharmacology was taught, repre-
senting 10 different degrees (7 non-vocational, 3 voca-
tional). For the purposes of analysis, the 10 degrees were
grouped into four distinct degree programs (Table 4).
A further 10 courses were identified into which phar-
macology is taught across 13 degree programs. Given
the diversity of structure, scope and duration of these
varied degree programs, to merge them into a single cat-
egory that might be called allied health would potentially
mask important differences in approaches to delivery,
breadth of content and assessment. Therefore, this data-
set was not included in the analysis presented here.
The median student enrolment numbers for courses
that taught pharmacology for each degree program var-
ied widely (Figure 1), with medicine and nursing having
the largest cohort sizes and science having far fewer
students enrolled. Given the marked cohort size range
within certain degree programs, the median provides a
better representation of a potentially skewed distribution.The smaller cohort sizes (5-20) mainly represent the in-
clusion of specialised courses (e.g. advanced practice and
research-based courses) within each degree program.
Across programs, pharmacology was taught most often at
second and third year levels in science and pharmacy pro-
grams, whereas in nursing and medicine it was taught
mainly at first and second year level (Table 5).
The difference in approaches to the delivery of phar-
macology is reflected in a comparison of the extent of
teaching integration across degree programs (Figure 2).
In science degree programs, pharmacology was taught
mainly as one or more stand-alone course(s), whereas in
medicine and nursing the pharmacology content was
more likely to be integrated across a number of courses
or with other discipline material within courses. By con-
trast, the teaching of pharmacology was evenly split be-
tween stand-alone and integrated courses in pharmacy
at the institutions surveyed.
Breadth and coverage of pharmacology content in
different degree programs
All but one of the 16 lecture themes (Table 3) were
taught in each of the degree programs. The exception is
Table 5 A comparison of the timing of pharmacology delivery across degree programs
Year of degree Science (n = 59) Pharmacy (n = 41) Nursing (n = 24) Medicine (n = 27)
1st year 3.5% 2.4% 25% 25.9%
2nd year 27% 21.9% 54.2% 29.6%
3rd year 61% 41.5% 0 18.5%
4th year 6.5% 24.4% 4.2% 11.1%
5th year 0 9.7% 16.7% 7.4%
6th year 0 0 0 3.7%
Not specified 2% 0 0 0
Data are expressed as the number of courses offered in a given year as a percentage of total courses offered in each program, where n = number of courses
surveyed per degree program (as identified in Table 4).
Note: In Australia, basic science and nursing programs are of 3 years duration; Pharmacy programs are 4 years; and Medicine programs can be 4, 5 or 6 years,
with undergraduate programs of longer duration. Later years are likely to be at Honours level or equivalent.
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nursing courses surveyed (Table 6). The lecture themes
analgesia/anaesthesia/anti-inflammatories, pharmacoki-
netics and pharmacodynamics were amongst the most
widely distributed and were taught in 50% or more of
the courses surveyed in all degree programs, with the
exception of pharmacy. As can be seen in Table 6, there
was notable variation across degree programs for certain
lecture themes.
The percentage of lecture topics taught within each as-
sociated lecture theme was determined for the four de-
gree programs (Table 7). As indicated by this parameter,
lecture topics that addressed a given theme were more
broadly covered in medicine degree programs (median
percentage 48%). On average fewer topics per theme
were addressed in science and nursing programs. No
one degree program covered all topics across all themes,
though the number of missing topics varied between
programs with 5 topics not addressed in lectures for
science and 6 for medicine as compared to 19 topics



















Science Pharmacy Nursing Medicine 
Integrated 
Stand Alone 
Figure 2 A comparison of the nature of the delivery of
pharmacology across degree programs. Each course within a
degree program was evaluated to determine whether pharmacology
was presented as stand-alone content or was integrated within that
course with material that crossed a number of disciplines, of which
pharmacology was only one.The number of lectures on topics within each theme
was calculated to provide an index of coverage in each
degree program (Figure 3). This analysis revealed that in
pharmacy most lecture themes had a greater number of
lectures per theme, compared to other degree programs.
In science degree programs some themes (e.g. Drugs of
Abuse, Drug Design & Development) had similar coverage
to that in pharmacy. Overall, there were fewer lectures per
theme in medicine and nursing when compared to science
and pharmacy programs.
Course delivery
The various methods of course delivery and the time
allocated to each method for each of the degree pro-
grams were compared (Table 8). These included both
traditional (lectures, practicals and tutorials) and non-
traditional (computer simulations, workshops, problem-
based learning (PBL) tutorials, online) teaching approaches,
as well as project work. Non-traditional teaching me-
thods were less frequently used compared with tradi-
tional approaches.
The overwhelming majority (90% or above) of courses
continue to use lectures, although the number of hours
allocated to lectures varied considerably. Of time de-
voted to activities other than lectures, practical classes
still dominated in science degree programs, with 63% of
courses offering wet-labs (ranging from 1-48 hours). A
third of courses in science also offered computer-based
practicals (i.e. computer modelling (12%) and computer
simulation (22%)). Strikingly, it was rare for courses in
non-science degree programs to utilise practical sessions
for pharmacology teaching. Tutorials predominated in
pharmacy (70%) relative to other degree programs but
none were identified as PBL tutorials. Medicine pro-
grams showed a much higher percentage of courses that
used PBL tutorials (37%). In the nursing degree program
two fully online courses were included in the survey; this
accounts for greater than 60 hours allocated to this
method of course delivery. Pharmacology research pro-
jects were offered in one-quarter to one-third of all
Table 6 A comparison of course content by lecture theme across degree programs, depicted as frequency of lecture
themes taught (percentage) across degree programs
Lecture theme in rank* order Mean (%) Science
(n = 59) (%)
Pharmacy
(n = 41) (%)
Nursing
(n = 24) (%)
Medicine
(n = 27) (%)
Analgesia/Anaesthesia/
Anti-inflammatories
53 ± 10 51 42 67 52
Pharmacokinetics 51± 10 58 37 58 52
Pharmacodynamics 50 ± 16 63 27 58 52
Neuropharmacology 45 ± 2 47 42 46 44
Cardiovascular and Renal Drugs 42 ± 10 37 32 54 44
Chemotherapy 39 ± 17 31 20 58 48
Metabolic/Endocrine/Genital Drugs 39 ± 10 41 32 33 41
Xenobiotic Metabolism and Toxicology 37 ± 5 36 27 50 41
Drugs of Abuse 34 ± 9 34 22 42 37
Respiratory Drugs 32 ± 6 31 24 38 33
Drug Design and Development 32 ± 17 56 24 21 26
Miscellaneous 28 ± 9 24 24 21 41
Gastrointestinal Drugs 22 ± 9 15 15 33 26
Complementary Medicines 22 ± 2 20 22 25 22
Musculoskeletal Drugs 19 ± 7 14 24 13 26
Future Therapies 13 ± 13 10 10 0 30
Error in the "Mean" column represents the standard deviation. Courses were evaluated for the presence or absence of material taught covering each theme. An
individual course might cover some, all or none of the identified themes and therefore, a stand-alone pharmacology course might be expected to be represented
in each percentage whereas an integrated course might be represented only in a single percentage within a degree program.
*Ranking is based on the mean frequency of lecture themes taught (percentage) across degree programs from highest to lowest.
n = number of courses surveyed.
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in nursing and medicine.
Summative assessment in pharmacology
Various types of in-semester summative assessment were
used across the degree programs (see Table 9) with sci-
ence and pharmacy programs using all formats identified
to some extent. In science, the most common format
was laboratory reports (24% of courses using this form
of in-semester assessment), whereas pharmacy courses
were more likely to use assignments (20%), reflecting the
difference in the use of practicals (wet labs) in each de-
gree program. By contrast, nursing and medicine were
more likely to employ pen-and-paper quizzes in prefe-
rence to other methods (30% and 31% respectively).
For medicine and nursing the summative assessment
format that comprised the highest percentage belonged
to the category called Other suggesting that the list pro-
vided for participants was not sufficiently comprehen-
sive. For pharmacy this category represented the second
most common format, while for science it was the fourth
most common. For science, activities in this category in-
cluded assessment of data, critiquing of papers, journal
club presentation and participation, participation in
group discussions, mid-semester examinations, literature
reviews, and enquiry-based learning case reports. Forpharmacy, this included workbook learning activities,
clinical cases, and drug reports. Other assessment types
in nursing included those listed for pharmacy, as well as
mid-semester examinations. Finally, for medicine Other
assessment types included workplace supervisor reports,
National Prescribing Service case studies, online open
book assessment of tutorials, and problem-based lear-
ning tutor marks.
By contrast to the high degree of variability of
in-semester assessment, the style of end-of-semester
examination was much more conserved across degree
programs (Table 10). The primary format for theory ex-
aminations combined multiple-choice questions (MCQ)
with short answer questions (SAQ) or essays, with be-
tween 51-81% of courses employing this format. Add-
itionally, practical examinations in the form of objective
structured clinical examinations (OSCEs) were utilised
for those degree programs requiring application of cli-
nical practical skills.
These similarities in assessment are reinforced when
the proportion of assessment during semester was com-
pared with the value of the end-of-semester examination
(Figure 4). In general, the end-of-semester examination
was worth 50-80% of the overall grade regardless of the
program evaluated. Eight percent of courses surveyed
had no end-of-semester examination (4 science degree
Table 7 A comparison of the number of lecture topics per theme across degree programs
Lecture theme (total no. topics per theme) Science (n = 59) (%) Pharmacy (n = 41) (%) Nursing (n = 24) (%) Medicine (n = 27) (%)
Pharmacokinetics (7 topics) 37 ± 4 40 ± 7 29 ± 6 52 ± 9
Analgesia/Anaesthesia/Anti-inflammatories
(11 topics)
30 ± 4 41 ± 6 32 ± 6 45 ± 9
Pharmacodynamics (13 topics) 36 ± 4 45 ± 11 26 ± 7 36 ± 9
Neuropharmacology (21 topics) 27 ± 3 31 ± 4 31 ± 5 28 ± 7
Cardiovascular and Renal Drugs (7 topics) 51 ± 6 75 ± 11 54 ± 10 76 ± 10
Chemotherapy (6 topics) 46 ± 6 54 ± 12 45 ± 10 61 ± 10
Xenobiotic Metabolism and Toxicology (11 topics) 31 ± 4 25 ± 6 22 ± 5 34 ± 8
Metabolic/Endocrine/Genital Drugs (11 topics) 23 ± 5 58 ± 9 23 ± 5 35 ± 9
Drugs of Abuse (5 topics) 44 ± 4 40 ± 8 42 ± 7 36 ± 7
Respiratory Drugs (3 topics) 44 ± 5 53 ± 13 48 ± 9 52 ± 8
Drug Design and Development (9 topics) 31 ± 4 24 ± 4 13 ± 5 37 ± 8
Miscellaneous (9 topics including “other”) 10 ± 2 12 ± 2 29 ± 10 26 ± 6
Gastrointestinal Drugs (4 topics) 39 ± 10 75 ± 14 59 ± 11 57 ± 12
Complementary Medicines (4 topics) 44 ± 9 22 ± 4 29 ± 6 67 ± 16
Musculoskeletal drugs (3 topics) 25 ± 8 57 ± 10 22 ± 11 67 ± 16
Future Therapies (2 topics) 58 ± 12 63 ± 18 0 50 ± 6
MEDIAN TOPIC PERCENTAGE 37 43 29 48
Data are expressed as average frequency ± s.e.m. For the courses identified in Table 6 that addressed pharmacology themes, each course was evaluated to
identify the topics covered within each theme. A percentage of coverage of each topic was then determined for those courses that addressed the theme. The
higher the number, the greater the number of topics covered in a theme. As an example, 58% of courses addressed pharmacokinetics as a theme in Science
degree programs (Table 6), the proportion of those courses that addressed the topic of drug metabolism was determined, followed by drug excretion and so
forth, then averaged for topics in the theme.
The median percentage coverage across the topics within each theme is also provided for overview.
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gree programs) and 6% of courses were assessed by
end-of-semester examination alone (9 medicine degree
programs).
Communication in pharmacology courses
Web-based facilities for communication between staff
and students were widely utilised across courses and
degree programs (96% science, 100% pharmacy, 100%
nursing, 100%, medicine). The main roles for this commu-
nication were online announcements, email group lists
and online discussions.
Evaluation of pharmacology teaching
In all degree programs with the exception of medicine,
the most common method employed to obtain student
feedback on teaching consisted of a mix of structured
and open-ended questions. In medicine, evaluation
consisted primarily of a structured question format.
Evaluations were generally carried out at the univer-
sity level and conducted once per semester across all
degree programs.
Discussion
In the current study, we undertook a national survey of
the current practice of pharmacology teaching andsummative assessment. We determined the breadth and
coverage of pharmacology curricula across four different
degree programs, allowing content, teaching approaches
and summative assessment activities to be compared.
Defining the current approach to the pharmacology
curricula
Data was obtained from 147 courses, taught in 10 diffe-
rent degrees, which were grouped into four different de-
gree programs (Table 4); data from these courses were
then collated to provide a snapshot of pharmacology
teaching across the degree programs. The focus of this
survey was to provide an overview of the current ap-
proaches to the delivery of content, types and weighting
of in-semester versus end-of-semester summative assess-
ment and breadth and coverage of topics within the field
of pharmacology. While examination of the weighting of
each assessment task within each degree program as well
as various types of formative assessment would have
been useful, this facet was not directly addressed in this
project.
A difference was noted in the timing of the delivery of
pharmacology content between degree programs. More
than half of the medicine courses and three-quarters of
nursing courses concentrated pharmacology teaching to






















Figure 3 A comparison of index of coverage across degree programs. The index of coverage indicates the number of lectures allocated to a
lecture theme relative to the number of topics taught. Data are expressed as: average number of topic lectures per themetotal number of topics per themeð Þ fraction of topics taught per themeð Þ. Lecture themes
ranked from left to right on the basis of mean lecture theme percentage across degree programs from highest to lowest. An index of greater
than 1 represents more than 1 lecture taught per lecture topic.
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duration depending on the course entry level offered (i.e.
undergraduate degrees into which students can enter
either directly from secondary school and is 5-6 years
duration or after completing at least one university de-
gree for which the medical degree is of 4 years duration)
and nursing degrees have a 4 year duration. Pharmacy
and science degree programs, by contrast, have courses
towards the middle to latter stages (second and third
years) of their respective programs (pharmacy 63%; sci-
ence 88%), with the majority of pharmacy degrees of
4 years duration, and science programs 3 years (4 years
for a science honours degree). The differences in timing
for medicine and nursing compared with other degree
programs may be associated with one or more of the
following factors: the early timing of clinical placements
in nursing; the division of the medical degree into pre-
clinical and clinical years; that Australian medical degrees
are delivered as either undergraduate or postgraduate de-
grees with different degree durations; and that pharmaco-
logy is being increasingly taught as part of an integrated
curriculum. By contrast, pharmacology is often offered for
the first time at the second year level in science followingcompletion of pre-requisite first year sciences such as
chemistry, mathematics and biology.
In order to evaluate pharmacology course content, 16
lecture themes were developed. The sixteenth theme
(Miscellaneous) covered a mixture of topics while the
other 15 lecture themes correlated closely with the sub-
ject areas provided in the survey of pharmacology cour-
ses in BSc degrees (UK) [10] and US medical schools
[14]. While clinical pharmacology was not identified as a
theme in our survey, perusal of Table 3 shows that as-
pects of clinical pharmacology were represented across
the lecture themes. Respondents also identified pres-
cription writing as a specialised topic within the Miscel-
laneous theme.
Although there was a high level of congruence with re-
spect to lecture themes across degree programs (Table 6),
such that content boundaries were broadly similar, there
were notable differences in coverage (as represented by
the calculated index) and to a lesser extent the breadth
of lecture themes (Table 7 and Figure 3). For example,
more time was devoted to drug design and development
in science degree programs than that provided to stu-
dents enrolled in medicine degree programs. Overall, the
Table 8 A comparison of the type of, and time allocated to, teaching methods across degree programs
Teaching method Science (n = 59) Pharmacy (n = 41) Nursing (n = 24) Medicine (n = 27)
Lectures1 90% 90.2% 91.7% 100%
hours allocated 26 (4 to 48) 36 (0 – 60) 12 (3 – 50) 12 (5 – >60)4
Practicals (wet labs)2 62.7% 19.5% 4.2% 3.7%
hours allocated 8 (1 to 48) 7.5 (3 – 15) 4 3
Computer modelling 11.8% 4.9% 0 0
hours allocated 7 (4 to 18) 2.5 (2 – 3) 0 0
Computer simulations 22% 14.6% 0 11%
hours allocated 6 (3 to 27) 4 (3 – 6) 0 2 (1 – 3)
Tutorial 44% 70.7% 50% 40.7%
hours allocated 5 (1 to 33) 12 (2 – 54) 10 (3 – 16) 4 (2 – >60)
Computer tutorial 13.5% 7.3% 0 3.7%
hours allocated 3.5 (1 to 8) 2 (2 – 3) 0 1
PBL tutorial 11.8% 0% 8.3% 37%
hours allocated 4 (1 to 16) 0 4.5 (3 – 6) 8 (3 – 12)
Workshop 11.8% 31.7% 8.3% 14.8%
hours allocated 6 (1 to 21) 12 (2 – 24) 9 4 (3 – 36)
Online 8.5% 9.7% 12.5% 3.7%
hours allocated 19 (2 to all)3 22 (2 – 36) >60 (30 – >60)4 2
Project 39% 26.8% 4.2% 3.7%
hours allocated 12 (2 to >60)4 10 (2 – 10) 18 10
Frequency of courses that utilise the listed teaching methods is expressed as a percentage of total number (n) of courses surveyed in each program. Hours
allocated are expressed as median number of hours with ranges in brackets.
Note:
1Science courses that do not utilise lectures: one is online and four are Honours courses. Of the four Pharmacy courses that do not utilise lectures, two are fourth year
courses and two are professional practice courses. The two Nursing courses that do not utilise lectures are fully online courses.
2The term “practicals” is synonymous with laboratory classes.
3‘all’ indicates that the entire course is delivered online.
4>60 refers to greater than 60 hours spent using the particular teaching method, and is generally indicated for Honours (research only) courses as well as online courses.
Table 9 A comparison of in-semester summative









Laboratory report 23.9% 7.4% 2.5% 0
Research Project 10.3% 4.6% 0 6.2%
Essay 4.5% 8.4% 2.5% 0
Quiz: pen-and-paper 9.7% 13.7% 30% 31.2%
Quiz: online 1.9% 1% 7.5% 0
Assignment 14.2% 20% 12.5% 15.6%
Exercise 7.1% 11.5% 10% 0
Presentation (oral or poster) 13.5% 16.8% 5% 3.1%
Thesis 1.3% 1% 0 0
Thesis defence 1.3% 1% 0 0
Other 12.3% 14.7% 30% 43.7%
Data are expressed as frequency (percentage) of courses using in-semester
summative assessments surveyed in each program.
n = number of courses surveyed.
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provided with more lecture hours across the majority of
pharmacology topics than students in other degree pro-
grams (Figure 3). However, the breadth of topics covered
in nursing degree programs (84% of topics) was less than
that in pharmacy, medicine or science (92% of topics for
pharmacy; 95% for medicine; 96% for science (data not
shown)). The survey design did not allow the index of
theme coverage to be considered equivalent to the depth
in which the theme was taught, and it is recognised that
a greater number of lectures allocated to topics within a
theme does not necessarily indicate that the theme was
taught in greater depth.
Lectures were the most common mode of teaching in
all degree programs thereby justifying the use of lecture
themes and lecture topics to identify curriculum con-
tent. However, caution must be exercised when using
lecture themes to reflect course content, as the methods
of delivery differed widely across degree programs. For
example, in science degree programs, practical classes
were common whereas PBL tutorials (or a variation of this
mode) were relatively frequent in medicine programs and
Table 10 A comparison of end-of-semester examination styles across degree programs
End-of-semester exam type Science (n = 59) Pharmacy (n = 41) Nursing (n = 24) Medicine (n = 27)
Theory examination: only MCQ 5.3% 4.8% 9.5% 15.1%
Theory examination: only SAQ or Essay 38.6% 11.9% 4.8% 3%
Theory examination: mix of MCQ/SAQ or Essay 50.9% 66.6% 81% 60.6%
Practical examination: mix of MCQ/SAQ or Essay 1.8% 2.4% 0 3%
Practical examination: OSCE 0 14.3% 0 12.1%
Other 3.5% 0 4.8% 6.1%
Data are expressed as percentage of total end-of-semester examinations surveyed for each degree program.
n = Number of courses surveyed.
MCQ =Multiple-choice question.
SAQ = Short-answer question.
OSCE = Objective structured clinical examination.
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ching coverage is generally lower for medicine must be
viewed in the context of the integrated approach in me-
dical schools in which PBL tutorials or similar types of
teaching approaches address topics and themes in a
non-traditional manner. Furthermore, teaching within
an integrated course may allow for more focused teaching
whereas in stand-alone courses time may be spent provid-
ing context and relevant physiological/pathophysiological
background. Nevertheless, it is reasonable to propose that
there is close alignment between content taught in lec-
tures with content taught using other modes of teaching
so that lecture themes and topics would be expected to be
a fair approximation of course content.
The predominance of lectures in so many programs is
noteworthy, given the recent trend to move away from
such a traditional method of delivery. As mentioned, the
use of PBL and other non-traditional teaching methods
is more common in the health-related fields when com-
pared with the science degree programs. The reasons for
which lecture delivery have been retained is/are unclear,



























Figure 4 A comparison of the relative proportion of in-
semester and end-of-semester assessment across degree
programs. Data are expressed as the median percentage of
assessment across the courses surveyed in each degree program.of the lectures was not explored in this survey; thus
it is possible that they varied from didactic to more
interactive discussion-based styles. Additionally, the effi-
ciency with which curriculum content may be delivered to
large numbers of students should not be discounted. The
demonstration that lectures form a major proportion of
teaching may offer a valuable opportunity for curriculum
reconsideration, renewal and redesign.
Pedagogic approach, graduate destination and discipline
integrity
While lectures were the most common mode of delivery
of course content, clear differences emerged with respect
to additional modes of teaching and types of assessment
across degree programs. For example, in science degree
programs scientific enquiry, laboratory skills and re-
search methodology were emphasised, as seen by the in-
clusion of laboratory work, laboratory reports and thesis
writing. On the other hand, tutorials and workshops pre-
dominated in the vocational, health-related degree pro-
grams where clinical reasoning skills were accentuated
and OSCEs used. Thus, how pharmacology is taught and
the types of assessment used to evaluate the learning,
reflect graduate destinations.
Pharmacology is taught both in stand-alone courses
and in integrated curricula across degree programs and
institutions. In science degree programs pharmacology
was more likely to be taught in stand-alone courses,
whereas in medicine approximately 90% of pharmaco-
logy was taught within integrated curricula, with other
vocational health-related degree programs following a
similar trend to that of medicine. Arguably, discipline in-
tegrity and expertise is most readily retained and deve-
loped within stand-alone courses, thus science degree
programs may have a hitherto unrecognised and impor-
tant role to play in this regard. On the other hand, in
health-related degrees interdisciplinary teaching in an in-
tegrated curriculum may be advantageous to facilitate
the acquisition and integration of knowledge from a range
Lloyd et al. BMC Medical Education 2013, 13:153 Page 14 of 15
http://www.biomedcentral.com/1472-6920/13/153of biomedical sciences as well as a team-based approach
to patient management. Within integrated curricula, how-
ever, vigilance is required to ensure pharmacology is well
represented in order to foster, for example, safe prescri-
bing and lifelong learning [19].
Recognition of foundation principles and content
boundaries of pharmacology
Concerns raised about the level of pharmacology know-
ledge on the part of medical and nursing graduates
[1-5], as well as from industry [7], argue for maintenance
of discipline integrity to facilitate curriculum renewal
and redesign to address these deficiencies. While defin-
ing core knowledge in pharmacology has received con-
siderable attention [8-10,14,15], levels of knowledge and
competencies may be better defined by criteria expressed
as learning outcomes [20]. Evaluation of the data from
our survey suggests that broad, knowledge-based lear-
ning outcomes could be developed for key principles of
pharmacology that outline a minimum or threshold
standard of knowledge and competency for each degree
program. These would address questions of pharmacol-
ogy content boundaries [21] and reflect the central role
that pharmacology principles play in drug discovery, de-
velopment and registration processes and in the safe and
effective use of medicines by health professionals. It is
envisaged that these learning outcomes would be con-
structed with input from stakeholders in higher educa-
tion, pharmaceutical industry and health professions.
Further, we suggest that development of knowledge-based
learning outcomes for graduates of pharmacology would
be of value to course designers and regulators involved in
the evaluation of various other allied health degree pro-
grams seeking an expansion of their pharmacological
roles, such as to obtain limited or extended prescription
rights.
Conclusion
The survey provides an overview of current approaches
to pharmacology teaching and summative assessment in
science, pharmacy, nursing and medicine degree pro-
grams in Australia and identifies a high degree of con-
gruence of curriculum content between these degree
programs. We believe that the observed similarities and
differences in pharmacology teaching, content and me-
thods across degree programs can inform curriculum re-
newal and development. This provides the basis and
rationale for development of knowledge-based learning
outcomes for pharmacology that can inform pharma-
cology teaching across degree programs with minimum
standards articulated for each degree program. Since the
identity of pharmacology is not readily defined [22-24],
defining what needs to be taught in differing degrees as-
sumes an importance hitherto not fully appreciated. Wesuggest that the development of broad, knowledge- and
competency-based learning outcomes for pharmacology
would lead to greater collaboration between experimen-
tal and clinical pharmacologists in the teaching of this
important discipline to students in science, pharmacy,
nursing and medicine degree programs.
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